Introduction
Parkinson’s disease treatment may involve several medications designed to manage symptoms throughout the day. For some patients taking levodopa/carbidopa, the medication’s benefits may begin to wear off before the next scheduled dose. These periods are known as “off” episodes and can allow symptoms such as stiffness, slowed movement, or tremor to return.
Ongentys contains opicapone, a selective and reversible COMT inhibitor designed to be used alongside levodopa/carbidopa. By inhibiting COMT, Ongentys reduces the breakdown of levodopa and helps increase the amount of levodopa available over time.
This medication is taken once daily at bedtime and must be taken on an empty stomach. Because it is a brand-name specialty medication, treatment costs can vary based on insurance coverage, pharmacy benefits, formulary status, and other factors.
For patients concerned about the cost of Ongentys, patient assistance programs may provide potential options for improving medication affordability. Prescription Hope helps eligible patients navigate prescription assistance options and medication access.
What Is A Patient Assistance Program?
Understanding Ongentys Prescription Assistance
Medications for Parkinson’s can be extremely expensive, which often leaves patients searching for Ongentys prescription assistance or Parkinson’s medication assistance programs.
Manufacturers of these medications understand the financial burden that results in patients searching for financial relief for the high cost of medications. In an effort to reduce the financial burden of treatment, many manufacturers offer patient assistance programs to help qualified patients.
These programs are designed to provide affordable medications to qualified patients. However, they can be difficult to navigate, which leaves patients frustrated when applying on their own.
How Expert Advocates Help Make Ongentys More Affordable
Personalized Medication Assistance
Do you need trusted patient advocates to assist you with applying for Ongentys patient assistance? Prescription Hope is here for you. When you enroll with Prescription Hope, you get a team of dedicated patient advocates that takes care of the application process for Ongentys affordability assistance programs, from beginning to end.
Our dedicated team of specialists oversees every step of the medication assistance application process, including completing forms and collecting necessary documents and signatures, coordinating with healthcare providers and manufacturers, and navigating the complexities of patient assistance programs.
Ongoing Patient Support
At Prescription Hope, we do more than help patients access medication application assistance services; we also provide ongoing medication assistance. Our team handles the administrative details, including form and document updates, issue resolution, program monitoring, annual renewals, and refill scheduling. Our patient assistance advocates are here to support you every step of the way.
Navigating Treatment Costs
Although Parkinson’s medications can be very costly, Prescription Hope’s medication cost assistance can help make treatment more affordable.
For $70.00 per month, per medication, patients can access Parkinson’s medication assistance without any hidden charges or fees, variable pricing systems, or additional surprise medication costs.
With Prescription Hope, qualified patients can feel more confident about managing the cost of Ongentys treatment. We handle the full application process and assist with refill scheduling along the way.
Ongentys Patient Assistance Eligibility
General Eligibility Requirements
While the best way to determine your specific Ongentys patient assistance qualifications is by enrolling with Prescription Hope, it can also help to understand the general requirements for patient assistance programs.
These typically include:
- Income: Each program has its own income guidelines.
- Insurance: Each program sets its own requirements for insurance coverage status.
- Prescription: Qualified patients must have a valid prescription for the name-brand medication they are applying for.
- U.S. Residency: Qualified patients must be legal residents of the United States.
Simple Enrollment With Expert Support
Getting Started With Enrollment
Are you ready to enroll in a patient assistance program? Get started with Prescription Hope today. Enrollment involves just six simple steps.
- Submit Information: Our online form takes only a few minutes to complete.
- Advocate Contact: A patient advocate will reach out to you within 1 to 2 business days.
- Document Collection: After a quick prequalification, our team will gather the necessary documents.
- Provider Coordination: We coordinate with your healthcare provider to obtain the required signatures.
- Program Submission: Our team prepares and submits your Ongentys assistance application packet, then continues to follow up with the manufacturer.
- Medication Delivery: Once approved, qualified patients can generally expect to receive their medication within 2 weeks, although shipping times may vary. Medications are shipped directly from the manufacturer to either your home or your doctor’s office.
Understanding Ongentys
How Ongentys Works
Ongentys contains opicapone, a selective and reversible inhibitor of catechol-O-methyltransferase, or COMT.
COMT is an enzyme involved in the metabolism of levodopa. Because it is used with levodopa/carbidopa, inhibiting COMT helps reduce the breakdown of levodopa and increases the amount of levodopa available over time.
By helping levodopa remain available for longer, this medication can extend the beneficial effects of levodopa/carbidopa. This may help reduce the amount of time Parkinson’s symptoms return between doses.
This medication is therefore used as an adjunctive medication rather than as a stand-alone treatment for Parkinson’s disease. Its purpose is to help extend the effects of levodopa/carbidopa in patients experiencing “off” episodes.
What Conditions Does Ongentys Treat?
Ongentys is FDA-approved as adjunctive treatment to levodopa/carbidopa for patients with Parkinson’s disease who experience “off” episodes.
An “off” episode occurs when the effects of levodopa/carbidopa begin to wear off before the next dose. During these periods, Parkinson’s symptoms such as stiffness, slowed movement, or tremor may return or become more noticeable.
This medication is not approved as a stand-alone treatment for Parkinson’s disease. It is used together with levodopa/carbidopa to help extend the medication’s beneficial effects.
The FDA initially approved the medication in 2020. Safety and effectiveness have not been established in pediatric patients.
Benefits of Treatment
For appropriately selected patients with Parkinson’s disease experiencing “off” episodes, Ongentys can help extend the effects of levodopa/carbidopa.
Reducing “off” time may provide patients with more time during the day when Parkinson’s motor symptoms are better controlled. Ongentys may also increase time spent in the “on” state and provide a convenient once-daily adjunctive treatment.
Because this medication increases the effects of levodopa, it can also cause or worsen dyskinesia, or involuntary movements. Individual treatment responses vary, and the healthcare provider determines whether Ongentys is appropriate based on the patient’s symptoms, other medications, and overall treatment plan.
Important Safety Information and Side Effects
Ongentys does not carry an FDA Boxed Warning. However, its prescribing information contains important warnings and precautions involving cardiovascular effects, sleepiness, low blood pressure, dyskinesia, hallucinations and psychosis, impulse-control behaviors, and withdrawal-related complications.
Contraindications
Ongentys is contraindicated in patients taking non-selective monoamine oxidase (MAO) inhibitors and in patients with pheochromocytoma, paraganglioma, or another catecholamine-secreting neoplasm.
Examples of non-selective MAO inhibitors include phenelzine, isocarboxazid, and tranylcypromine.
Cardiovascular Effects
Ongentys can affect the metabolism of certain catecholamine-related medications, including epinephrine, norepinephrine, dopamine, dobutamine, and isoproterenol.
Using these medications with Ongentys may increase the risk of:
- Abnormal heart rhythms
- Increased heart rate
- Excessive changes in blood pressure
Other side effects include:
- Falling asleep during daily activities
- Low blood pressure and fainting
- Dyskinesia
- Hallucinations and Psychosis
- Impulse Control and Compulsive Behaviors
- Withdrawal-Emergent Hyperpyrexia and Confusion
Pregnancy
There are no adequate human data establishing the developmental risk of Ongentys during pregnancy.
Animal studies did not identify adverse effects on embryofetal development in rats at exposures substantially above the recommended human dose. However, studies in pregnant rabbits found an increased incidence of structural abnormalities at all doses tested, and a no-effect dose for embryofetal development was not identified.
Because this medication is always administered with levodopa/carbidopa, pregnancy considerations also involve the accompanying Parkinson’s disease treatment.
Patients who are pregnant or planning pregnancy should discuss Ongentys and their overall treatment plan with their healthcare provider.
Breastfeeding
There are no available human data regarding whether opicapone is present in human milk, its effects on a breastfed infant, or its effects on milk production.
Animal studies found opicapone or its metabolites in rat milk.
Patients and healthcare providers should consider the developmental and health benefits of breastfeeding along with the mother’s clinical need for Ongentys and any potential effects on the breastfed infant.
Common Side Effects
- Constipation
- Increased blood creatine kinase
- Hypotension or syncope
- Weight loss
- Dizziness
- Dry mouth
Access to Multiple Medications
Support Beyond Ongentys
Looking for support with Parkinson’s prescriptions or access to other specialty medications?
Prescription Hope also helps qualified patients apply for assistance with other Parkinson’s treatments, including Tasmar, another COMT inhibitor, as well as the Neupro patch.
Prescription Hope regularly helps qualified patients apply for multiple medication assistance programs at the same time. Whether you need help with one medication or several, our dedicated team provides comprehensive service for a simple $70.00 per medication, per month.
Why Choose Prescription Hope for Ongentys Assistance
Patient-Focused Medication Support
For the past two decades, patients have trusted Prescription Hope for patient-centered assistance and support that helps improve prescription affordability for medications like Ongentys. Our Florida-based medication access specialists can help qualified patients access Ongentys prescription support through Prescription Hope.
Simplified Access to Specialty Therapies
Our Ongentys specialty medication access and prescription assistance services help provide patients with the support they need to reduce medication costs and feel more confident about managing prescription prices.
Ongoing Prescription Assistance
Prescription Hope does more than help patients access Ongentys financial support; we also provide ongoing medication assistance. Our team of patient advocates handles form and document completion, issue resolution, annual renewals, and even refill scheduling.
Need access to affordable brand-name medications like Ongentys? Enroll with Prescription Hope today and let our patient assistance advocates help you get started.